Results 61 to 70 of about 5,559 (204)
European Journal of Clinical Investigation, Volume 56, Issue 4, April 2026.In this large European–Asian cohort of patients with atrial fibrillation, liver disease was linked to lower oral anticoagulant use—particularly in Europe—and to higher risks of mortality and cardiovascular events. These findings highlight the adverse impact of liver disease, especially when oral anticoagulation is withheld.
Davide Antonio Mei +9 more
wiley +1 more source
Кардиоваскулярная терапия и профилактика, 1970 Aim. To study clinical effectiveness and safety of propafenone and amiodarone in patients with arterial hypertension (AH), coronary heart disease (CHD), chronic heart failure (CHF) with preserved left ventricular (LV) systolic function, and atrial ...
Yu. M. Pozdnyakov +3 more
doaj
Clinical Cardiology, Volume 49, Issue 3, March 2026.In Asian patients with hypertrophic cardiomyopathy, integrating NT‐proBNP with the clinical HCM‐AF score provides significant incremental prognostic value. This combined multiparametric assessment enhances the predictive accuracy for new‐onset atrial fibrillation, enabling more precise risk stratification and targeted clinical management.
Yi‐Peng Gao +10 more
wiley +1 more source
Oral propafenone as treatment for incessant supraventricular and ventricular tachycardia in children
, 1993 Incessant tachycardia, which can result in tachycardiainduced cardiomyopathy, is difficult to treat with conventional drugs. Better results are obtained with class Ic antiarrhythmic agents, but they may elicit proarrhythmias.
Bink - Boelkens, MTE, Beaufort-Crol, GCM
core +1 more source
Кардиоваскулярная терапия и профилактика, 2005 Aim. To study efficacy and safety of propafenone (loading single dose of 600 mg per os) in treating atrial fibrillation (AF) paroxysms. Material and methods. The study included 233 patients with persistent AF, aged 31-62 (mean age 57.6 ± 2.8 years), from
I. G. Fomina +3 more
doaj
Propafenone effects on the stable structures of A beta(16-22) system
, 2018 © 2018 Elsevier B.V. An extensive replica exchange molecular dynamics (REMD) simulation was performed to investigate the progress patterns of the molecular interactions of propafenone and Aβ16-22 system.
Ngo, Son Tung, Linh, Tran, Nguyen, Minh
core +1 more source
, 1996 Objectives. Our aim was to evaluate the benefits and risks of administering propafenone before electrical defibrillation for chronic atrial fibrillation.Background.
Santini, Massimo +5 more
core +1 more source
Frontiers in Physiology, 2019 Short QT syndrome variant 1 (SQT1) arises due to gain-of-function mutations to the human Ether-à-go-go-Related Gene (hERG), which encodes the α subunit of channels carrying rapid delayed rectifier potassium current, IKr.
Dominic G. Whittaker +7 more
doaj +1 more source
Propafenone-induced cardiac arrest: full recovery with insulin, is it possible? [PDF]
, 2013 Propafenone may cause mental depression, mania, convulsion, metabolic acidosis, hypotension, prolonged QRS, atrioventricular block, and cardiac arrest if it is taken at a dose greater than recommended.
GAZİ, EMİNE +4 more
core +1 more source
Experience with propafenone for the treatment of cardiac arrhythmias in children
The Turkish Journal of Pediatrics, 1990 The aim of this prospective study was to evaluate the efficacy of propafenone in suppressing various arrhythmias in a group of children who were patients in the Pediatric Cardiology Unit of Hacettepe University Children's Hospital. Seven of the 13
A Celiker +4 more
doaj